-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
-
Summary
-
Ambrx Biopharma, Inc. quarterly Liabilities history and growth rate from Q4 2022 to Q3 2023.
- Ambrx Biopharma, Inc. Liabilities for the quarter ending September 30, 2023 was $29.1M.